Literature DB >> 21463705

Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases.

Sylvain Ploux1, Annalisa Riviere, Sana Amraoui, Zachary Whinnett, Laurent Barandon, Stephane Lafitte, Philippe Ritter, Georgios Papaioannou, Jacques Clementy, Pierre Jais, Laurence Bordenave, Michel Haissaguerre, Pierre Bordachar.   

Abstract

BACKGROUND: A pacemaker recipient may be hospitalized recurrently with an infection of unknown origin despite detailed investigations.
OBJECTIVE: The purpose of this study was to investigate whether (18)F-fluorodeoxyglucose positron emission tomography/computerized tomography (FDG-PET/CT) scanning has a role in identifying pacing material infection in these difficult cases.
METHODS: Ten patients who presented with fever of unknown origin despite detailed investigations including transesophageal echocardiography underwent FDG-PET/CT scanning. Identification of increased FDG uptake along a pacing lead prompted the removal of the entire pacing system, whereas in the absence of increased FDG uptake the pacing material was left in place. Forty control pacemaker recipients underwent FDG-PET/CT scanning as part of investigation of malignancy.
RESULTS: Among the 40 patients in the control group, FDG-PET/CT scanning was normal in 37 (92.5%) patients. Among the 10 patients who presented with suspected pacing system infections, FDG-PET/CT scanning showed increased FDG uptake along a lead in six patients; as a result of this finding, these patients subsequently underwent complete removal of the implanted material. Cultures of the leads were positive in all six patients, confirming involvement of the leads in the infectious process. In the other four patients, the pacing system was left in place without objective signs of active lead endocarditis during follow-up.
CONCLUSION: This study demonstrates the potential value of FDG-PET/CT scanning in the diagnosis of pacing lead endocarditis in difficult cases. Increased FDG uptake along a lead in this clinical context appears to be a reliable sign of active infection.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21463705     DOI: 10.1016/j.hrthm.2011.03.062

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  21 in total

1.  Quantifying FDG uptake to diagnose cardiac device infections: When and how should we do it?

Authors:  Ron Blankstein; Edward J Miller
Journal:  J Nucl Cardiol       Date:  2015-10-22       Impact factor: 5.952

2.  FDG PET/CT in cardiac electronic devices infection: Now is the time to target guidelines implementation.

Authors:  François Rouzet; Fabien Hyafil; Dominique Le Guludec
Journal:  J Nucl Cardiol       Date:  2015-04-25       Impact factor: 5.952

Review 3.  Radiology of cardiac devices and their complications.

Authors:  J Dipoce; A Bernheim; H Spindola-Franco
Journal:  Br J Radiol       Date:  2014-11-20       Impact factor: 3.039

4.  Recommendations on nuclear and multimodality imaging in IE and CIED infections.

Authors:  Paola Anna Erba; Patrizio Lancellotti; Isidre Vilacosta; Oliver Gaemperli; Francois Rouzet; Marcus Hacker; Alberto Signore; Riemer H J A Slart; Gilbert Habib
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-24       Impact factor: 9.236

5.  Mycotic aneurysm of the superior mesenteric artery and other sequelae of prosthetic valve endocarditis on ¹⁸F-FDG PET/CT.

Authors:  Eugene J Teoh; Laura Backhouse; Badrinathan Chandrasekaran; Nikant K Sabharwal; Andrew M Beale; Fergus V Gleeson; Kevin M Bradley
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-04       Impact factor: 9.236

6.  Cardiovascular implantable electronic device infection: delayed vs standard FDG PET-CT imaging.

Authors:  Lucia Leccisotti; Francesco Perna; Mariaelena Lago; Milena Leo; Antonella Stefanelli; Maria L Calcagni; Gemma Pelargonio; Maria L Narducci; Gianluigi Bencardino; Fulvio Bellocci; Alessandro Giordano
Journal:  J Nucl Cardiol       Date:  2014-04-10       Impact factor: 5.952

7.  High performances of (18)F-fluorodeoxyglucose PET-CT in cardiac implantable device infections: A study of 40 patients.

Authors:  Ghoufrane Tlili; Sana Amraoui; Sana Amroui; Charles Mesguich; Annalisa Rivière; Pierre Bordachar; Elif Hindié; Laurence Bordenave
Journal:  J Nucl Cardiol       Date:  2015-03-19       Impact factor: 5.952

8.  Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis.

Authors:  Maryam Mahmood; Ayse Tuba Kendi; Saira Farid; Saira Ajmal; Geoffrey B Johnson; Larry M Baddour; Panithaya Chareonthaitawee; Paul A Friedman; M Rizwan Sohail
Journal:  J Nucl Cardiol       Date:  2017-09-14       Impact factor: 5.952

9.  18F-FDG PET/CT now endorsed by guidelines across all types of CIED infection: Evidence limited but growing.

Authors:  Fozia Zahir Ahmed; Parthiban Arumugam
Journal:  J Nucl Cardiol       Date:  2017-11-29       Impact factor: 5.952

10.  Role of ¹⁸F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective study.

Authors:  Maddalena Graziosi; Cristina Nanni; Massimiliano Lorenzini; Igor Diemberger; Rachele Bonfiglioli; Ferdinando Pasquale; Matteo Ziacchi; Mauro Biffi; Cristian Martignani; Michele Bartoletti; Fabio Tumietto; Giuseppe Boriani; Pier Luigi Viale; Stefano Fanti; Claudio Rapezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-07       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.